StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
OCEA

Ocean Biomedical, Inc.

OCEA OTC Pharmaceutical Preparations EDGAR ↗
$0.00
-0.00 -50.00%

Key statistics

from XBRL data in SEC filings
Market cap
$18.2K
Revenue (TTM)
Net income (TTM)
-$30.7M
EPS (TTM)
$-0.91
P/E ratio
Dividend yield
Free cash flow
Cash
$800K
Total assets
$1.58M
Gross margin
52-week range

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Delisting notice or listing-rule failure; Director or officer change; Other events Aug 5, 2025 8-K Delisting notice or listing-rule failure Jul 23, 2025 8-K Terminated a material agreement Jul 16, 2025 8-K Terminated a material agreement Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 29, 2025 8-K Delisting notice or listing-rule failure; Director or officer change; Other events Apr 23, 2025 10-K Fiscal year ended 2024-12-31 Apr 8, 2025 8-K Shareholder vote results Apr 1, 2025 8-K Other events Mar 26, 2025 8-K Delisting notice or listing-rule failure Mar 20, 2025 8-K Director or officer change Mar 10, 2025 8-K Unregistered sale of equity; Amended charter or bylaws Feb 26, 2025 8-K Amended charter or bylaws Feb 21, 2025 8-K Unregistered sale of equity; Other events Feb 12, 2025 8-K Delisting notice or listing-rule failure Jan 15, 2025 10-Q Quarter ended 2024-09-30 Jan 13, 2025 10-Q Quarter ended 2024-06-30 Dec 23, 2024 10-Q Quarter ended 2024-03-31 Dec 23, 2024 8-K Changed accountants Dec 17, 2024 8-K Delisting notice or listing-rule failure Dec 11, 2024 8-K Delisting notice or listing-rule failure Dec 9, 2024 8-K Changed accountants Dec 6, 2024 10-K Fiscal year ended 2023-12-31 Nov 25, 2024 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Nov 22, 2024 8-K Director or officer change Oct 29, 2024 8-K Delisting notice or listing-rule failure Oct 22, 2024 8-K Entered a material agreement Oct 17, 2024 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Aug 23, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jul 23, 2024 8-K Delisting notice or listing-rule failure; Regulation FD disclosure May 30, 2024 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Apr 24, 2024 10-Q Quarter ended 2023-09-30 Apr 15, 2024 10-Q/A Quarter ended 2023-06-30 Apr 15, 2024 10-Q/A Quarter ended 2023-03-31 Apr 15, 2024 8-K Director or officer change Mar 8, 2024 8-K Director or officer change Mar 4, 2024 8-K Delisting notice or listing-rule failure Jan 19, 2024 8-K Delisting notice or listing-rule failure Jan 17, 2024 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Nov 30, 2023